GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: example 356 [WO2020092375] | GS-1427 | GS1427
Compound class:
Synthetic organic
Comment: Emvistegrast (GS-1427) is an oral α4/β7 integrin inhibitor. It was designed to reduce α4β7 integrin-mediated recruitment of α4β7-expressing lymphocytes to the gut, as disease-modifying mechanism for inflammatory bowel disease. GS-1427 is one of the inhibitors claimed in patent WO2020092375A1 [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|